PHARMACOLOGICAL CHARACTERIZATION OF A NOVEL BIFUNCTIONAL ALDO-KETO REDUCTASE 1C3 INHIBITOR AND ANDROGEN RECEPTOR ANTAGONIST
$19,540FY2013Department of DefenseDOD
Trustees Of The University Of Pennsylvania, The
Trustees Of The University Of Pennsylvania, The